Fludarabine, Cyclophosphamide, and Rituximab Versus Pentostatin, Cyclophosphamide, and Rituximab in Previously Untreated or Treated B-Cell Chronic Lymphocytic Leukemia Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2008 by US Oncology Research.
Recruitment status was  Active, not recruiting
Sponsor:
Collaborator:
Astex Pharmaceuticals
Information provided by:
US Oncology Research
ClinicalTrials.gov Identifier:
NCT00254163
First received: November 9, 2005
Last updated: February 27, 2008
Last verified: February 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given